CMOCRO - Supporting the Search for Pharmaceutical Partners
Jinfo Blog
29th April 2015
Abstract
The CMOCRO site is a global repository of pharmaceutical suppliers and aims to support its users by providing relevant information regarding the suitability of prospective partners. Reviewer Ashish Shukla highlights a couple of his favourite features of this free-to-use site and what it offers organisations or individuals looking for partnering support.
Item
In this era of globalisation, aspiring organisations invest a considerable amount of time, money and energy in seeking potential partners.
There are a multitude of parameters (such as type of services offered, therapy areas served, regulatory compliance status of facilities, and others) that must be studied and compared between different prospective partners before one can arrive at any decision.
Supporting the Search for Pharmaceutical Partners
The CMOCRO site aims to support organisations and/or individuals in their quest for finding suitable business partners (see FreePint's recent Mini Review).
The site has an exhaustive list of pharmaceutical suppliers based across the globe, and provides an easy to use interface and free access to the database (registration required).
CMOCRO is a subsidiary of PharmaCircle and a joint venture with Drug Development & Delivery, two of the trusted names in the pharmaceutical knowledge management services, and the database is continuously updated and verified.
Company Comparisons
In our review of CMOCRO, two features caught our attention most. The site has a robust platform that allows users to select up to 20 companies and compare them. The output is a visual representation of similarities and differences between the selected companies.
We found this output easy to comprehend and helpful in top-line evaluation of how different companies are stacked against each other.
Depth of Information Offered
Another feature that impressed us while reviewing CMOCRO was the depth of the information. The CMOCRO team has primarily divided pharmaceutical suppliers into eight major categories, which are further divided into multiple sub-categories.
This layering of information is great help when we are looking for very specific information.
Find Out More
Along with the above two features, there are other features like "autosuggestion" and "location specific searches" that enhance the user experience considerably. Importantly, the user does not require a high-end training programme to be able to use this database.
Read about these features and the structure, functional aspects and promised business value of the CMOCRO database in FreePint's Mini Review of CMOCRO.
- Blog post title: CMOCRO - Supporting the Search for Pharmaceutical Partners
- Link to this page
- View printable version
- Mini Review of CMOCRO from PharmaCircle
Tuesday, 28th April 2015 - Specialist News Offerings - Pharma Sector
Wednesday, 10th December 2014 - Q&A with Adis Custom Intelligence Service - Bespoke Pharma Research & Analysis
Thursday, 16th October 2014
- Subscription Update for Pharmaceutical Companies
Wednesday, 8th April 2015 - AdisInsight Offers Single Point of Access to Entire Drug Lifecycle
Thursday, 19th March 2015
- Product Review of AdisInsight
Wednesday, 18th March 2015 - FreePint Report: Product Review of Cortellis
Tuesday, 22nd July 2014 - FreePint Report: Product Review of PharmaCircle
Thursday, 27th March 2014
Community session
11th December 2024
2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024
How are information managers getting involved with AI? Navigating privacy, ethics, and intellectual property
- 2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024 - All recent Jinfo Subscription content
31st October 2024 - End-user training best practice research
24th October 2024
- Jinfo Community session (TBC) (Community) 23rd January 2025
- Clinic on contracting for AI (Community) 11th December 2024
- Discussing news and AI strategies with the Financial Times (Community) 21st November 2024